Cresco Labs Reschedules Q1 2025 Earnings

LOS ANGELES- Cresco Labs Inc. has announced an updated schedule for its first quarter 2025 financial disclosures. The company will file its interim financial statements and Management’s Discussion and Analysis (MD&A) on Friday, May 30, 2025. A conference call and webcast to discuss the results is scheduled for Monday, June 2, 2025, at 8:30 a.m. Eastern Time.

The rescheduling follows a three-week period during which Cresco Labs collaborated with its independent auditors to complete the review of its financial statements. The company reported that the review concluded with no material changes from the preliminary results prepared for the initially planned release on May 9, 2025.

Cresco Labs is a vertically integrated cannabis company headquartered in Chicago, Illinois. The company operates in multiple states across the U.S., offering a portfolio of brands including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s, and Remedi. Its retail operations are conducted under the Sunnyside brand.